PODCAST · technology
Brom Podcast
by Brom Rector and Empath Ventures
The Brom Podcast covers the emerging psychedelics industry from a business, investing, cultural and social impact perspective. Episodes feature psychedelic CEOs, scientists, investors, and other change-makers operating in the weird, wonderful world of psychedelic medicine.Brom Rector is the founder and general partner of Empath Ventures, a venture capital fund that invests in early stage startups focused on psychedelic medicine.
Episodes
-
Dave Messina - YC founder turned investor talks TechBio
Ever wondered what Pioneer Fund’s Future of Health Fund is excited about? Want to know how to impress Dave Messina? Are you curious about how different funds communicate and interact? Give a listen to our first in a potential series of the Human 3 podcast: VCxVC talks, hosted by Samantha Rector....
-
$HIMS Q2 Results - our take as healthcare venture capitalists
Brom Rector and Sam Tabone from XEIA Venture Partners - a VC firm that invests in the future of human health, wellbeing and performance - discuss $HIMS Q2 results and the HIMS business more broadly. We spend a lot of time discussing the legality of HIMS current FDA strategy and how/if HIMS can...
-
Investing in Psychedelic BioTech [August 2025 webinar replay]
Watch the video recording on YouTube: https://youtu.be/BM6x59oMnKg?si=qF0xDvgUMvU60ctP 2025 has been the start of a bull period for psychedelic medicine. Psychedelic Biotechs like GH Research, Compass Pathways and Lykos Therapeutics are releasing impressive, late stage clinical trial data…
more -
Compass and ATAI latest news + are Psychedelics BACK in 2025?!
The past few years have been rough for psychedelic and shroom stocks, but recent news from ATAI (and Recognify), Compass Pathways and GH Research + positive regulatory tailwinds from RFK and MAHA make me think that Psychedelics are back on the menu in 2025. In this video I discuss: (0:00) - why...
-
Bryan Johnson's Neuralink competitor - with Kernel CEO Ryan Field
Ryan Field is the CEO of Kernel, a brain-computer interface company founded by Bryan Johnson. Kernel is a cutting edge, non-invasive BCI that uses fNIRS to image the brain. Imagine if getting an MRI was as easy as putting on a bike helmet: that's Kernel in a nutshell. Kernel is developing several...
-
How to start a VC fund
I interviewed Michael Huseby to learn about his life story and his new book: Fundamentals: Your Friendly Guide to Investment Funds and SyndicationsThis is a great listen for anyone interested in starting an investment fund or interested in making the transition from "practitioner" to…
more -
Beyond Neuralink - Investing in Brain Computer Interfaces [webinar replay]
Replay of our webinar on investing in brain computer interfaces. Join our upcoming July 30th event on investing in psychedelic biotech: psybio.org
-
Designing Novel Brain Drugs with Xylo Bio
Xylo is a biotech startup that is using computational methods to design novel brain drugs to treat mental health disorders and neurodegeneration. Many of their drug candidates are inspired by naturally occurring psychedelic drugs but are specifically designed to not induce hallucinations. Xylo's...
-
The BioIndustrial Revolution: Why Peter Thiel and Chris Sacca backed Arye's Biomanufacturing Startup
Arye Lipman is the cofounder of Biosphere, a startup that recently raised millions of dollars from Peter Thiel's Founders Fund and Chris Sacca's Lower Carbon Capital to Unleash Industrial Biomanufacturing at scale. Biosphere is replacing the 1950's steam bioreactor with a modern, UV-enabled…
more -
Compass Pathways Phase 3 Psilocybin trial results - Psychedelic Stock down 50%?! Emergency podcast!
Compass Pathways ($CMPS) released an interim readout from their Phase 3 trial of Psilocybin (COMP360) for treatment resistant depression (TRD). The data was positive and highly anticipated by the psychedelic community, but the stock dropped 50% on June 23rd. Brom Rector and Sam Tabone of XEIA...
-
The genetic revolution in treating neurodegenerative disease with Martin Jacko
Martin Jacko is the founder of Aperture Therapeutics, a startup developing ASO (Antisense Oligonucleotide) based therapies for neurodegenerative diseases like ALS. Aperture's approach is unique in how they are guided by genetic profiles of individuals who are naturally resilient to...
-
Brain implants without a hole in your skull - Wes Jones of Vonova
Wes Jones is the CEO of Vonova, a brain computer interface company that (unlike Neuralink) is enabling access to the brain without drilling a hole in your skull. Wes joins Brom Rector and Sam Tabone to discuss: (1:25) - how Wes got into neuro, background as a catheter engineer (6:30) - how Wes’s...
-
The BioPunk Revolution with Elliot Roth
Elliot Roth is the founder of the BioPunk community lab. He believes that biotech is broken and that "BioPunks" can fix it. Elliot sits down with Brom Rector and Sam Tabone to discuss: (0:00) - what is BioPunk (6:15) - steel-manning the status quo (13:45) - how can institutions be more BioPunk...
-
Can electricity cure brain cancer? Ben Woodington of Coherence Neuro on BCIs in oncology
Ben Woodington is the cofounder and CEO of Coherence Neuro. Coherence's lead product, the SOMA-1, is a brain computer interface (BCI) that is designed to treat Glioblastoma (a type of brain cancer). Coherence's cancer focus sets them apart from other BCI companies like Neuralink and Synchron. Ben...
-
Epigenetic Medicine with Laura Hsieh of TippingPoint Biosciences
Laura Hsieh is the founder of TippingPoint Biosciences, an epigenetic medicine startup that has developed a breakthrough method of drugging the entire chromatin network to create first-in-class epigenetic therapeutics. Laura sits down with Sam Tabone and Brom Rector to discuss: (1:11) Laura’s...
-
Top 10 Human 3 startups - brain implants, concierge longevity medicine, designer psychedelics and more
Brom Rector and Sam Tabone from XEIA get specific on what Human 3 actually looks like in practice by analyzing 10 startups through the Human 3 lens. We analyze the companies on the 5 pillars of Human 3 Distribution shifting potential - can this company elevate the already healthy in addition to...
-
Investing in Human 3 - the new epoch of health, wellbeing and performance
Sam Tabone, Partner at XEIA joins Brom on the podcast to discuss XEIA's "Human 3" thesis. Check out XEIA at https://www.xeiavp.com/ Timestamps 0:00 - why we created Human 3 - going from psychedelic medicine to the broader Human 3 space 8:00 - critiquing the Human 3 manifesto 12:00 regulatory and...
-
SEAL Team 6 Veteran & TARA Mind Founder Marcus Capone on Psychedelic Therapy: from SEALS to Startups
Marcus Capone is founder of TARA Mind. TARA Mind is an employee benefit provider that allows companies of all sizes to offer Ketamine therapy to their employees as a mental health benefit.Marcus is also the Chairman and Co-Founder of VETS: Veterans Exploring Treatment Solutions, VETS is a non...
-
AI designed mRNA therapies: a Universal Toolkit for Genetic Medicine? Google-backed founder explains
Amit Deshwar is the Founder & CTO of Kerna Labs. Backed by Gradient Ventures (Google's AI fund), Kerna Labs is building foundational AI models that aim to unlock the full potential of mRNA as the universal toolkit for genetic medicine. Kerna Labs' CSO is Melissa J. Moore, the former CSO of…
more -
Project Stargate, AI agents, is Trump transitioning us from the Anthropocene to the Synthocene?
Ramsay Brown, founder of Mission Control - a leading provider of AI agents / synthetic workers to the defense industry, joins us to discuss the end of the Anthropocene, what a world filled with synthetic labor looks like, Project Stargate, Trump and AI, why you need to be Rick Rubin and more.…
more -
Psychedelics and AI and in 2025 with Dillan DiNardo of Y Combinator-backed Mindstate Design Labs
Dillan DiNardo, the founder and CEO of Mindstate Design Labs, a drug development company using AI to enable the precision design of altered states of consciousness joins the podcast to discuss the state of psychedelics, AI, consciousness, why Marc Andreessen hates psychedelics, and the…
more -
Making Deep Brain Stimulation Minimally Invasive with MJ Antonini and Nicki Driscoll of NeuroBionics
Today’s guests are MJ Antonini & Nicki Driscoll, the founders of NeuroBionics, a neurotech startup out of MIT. NeuroBionics is making Deep Brain Stimulation minimally invasive though the development of nano fibers that are 10X thinner than traditional Deep Brain Stimulation leads - allowing them…
more -
Using AI to uncover nature's hidden cures - Lars Wilde of Pangea Bio
Lars Wilde is the cofounder of Pangea Bio - startup that uses AI to identify natural compounds and traditional remedies that may have medical applications. Prior to starting Pangea, Lars cofounded Compass Pathways and ATAI life sciences, both of which IPOd on the NASDAQ.
-
Advancements in Male Sexual Health w/ John Boghossian & Ryan Protzko of Kadence Bio
Can a succulent plant from South Africa treat premature ejaculation? John Boghossian and Dr Ryan Protzko from Kadence Bio think so. www.kadencebio.com
-
Can Skull Implants Treat Depression? Jacob Robinson & Motif Neurotech (Crossover Episode on Business Trip)
Can brain implants treat your depression? Ok, technically this would be a skull implant, not a brain implant - but still! Jacob Robinson from Motif Neurotech discusses the future of minimally invasive electronic medicine from mental health and beyond. This is a crossover episode from the Business...
-
Elliot Marseille - UC Berkeley Healthcare Economist on the Financial Viability of Psychedelic Therapy
Will MDMA and psychedelic therapy be affordable? There are lots of questions about the economic and financial future of psychedelic therapies. How much will they cost? Will insurance cover them? And more fundamentally, how does one even begin to quantify the value of a psychedelic experience?...
-
Founder of the AI Responsibility Lab, Ramsay Brown on AI Safety, AI Coworkers & ChatGPT doing DMT
🤖 ChatGPT & Dall-E today - misinformation, bias & worker displacement tomorrow. In a world where artificial intelligence is becoming increasingly advanced, it's more important than ever to ensure that AI systems are aligned with our values and behave in ways that are safe for humanity. But what...
-
Zach Haigney, Author of The Trip Report - Future Trends in Psychedelic Medicine
Zach Haigney is the author of The Trip Report, a newsIetter that covers the emerging psychedelic science, medicine, and policy landscape. In this conversation, Zach and Brom discuss emerging trends, questions and hot topics in the psychedelics industry including: The lines of tension between Drug...
-
Sam Banister - The Art and Science of Designing Novel Psychoactive Therapeutics
Sam Banister is a medicinal chemist and co-founder of Psylo. Psylo is an Australian psychedelic biotech company using machine learning assisted drug design techniques to developing novel psychedelic medicines to treat mental illness. Sam is here to help us understand how new chemical entities are...
-
Music For Psychedelic Therapy - Mendel Kaelen, Founder and CEO of Wavepaths
Mendel Kaelen is the CEO of Wavepaths. Prior to founding Wavepaths, Mendel Kaelen worked as a PhD and postdoctoral neuroscientist at Imperial College London since 2012, where his research was the one of the first to demonstrate music’s central role in psychedelic therapies. Wavepaths is a…
more -
Tom Feegel, CEO of Beond - Ending the Opiate Addiction Epidemic with Safe Ibogaine Treatment
Tom Feegel is the Founder and CEO of Beond. Beond exists to help end the opiate addiction epidemic with safe ibogaine treatment. In this episode Tom speaks on the severity of the opioid epidemic and explains how ibogaine assisted therapy can help heal those who are suffering from addiction. Tom...
-
Dillan DiNardo - CEO of Mindstate Design Labs | Creating Novel Psychoactive Drugs at Y Combinator
Dillan DiNardo is the CEO of Mindstate Design Labs - a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions. Mindstate's mission is to map the biological basis of the varieties of psychedelic…
more -
27: Juan Pablo Cappello - CEO of Nue Life
Mental health treatment is often inaccessible, inadequate, and ineffective. However, Nue Life is working to change this through its 360-degree approach to patient health, leveraging ketamine and the integration of tech. Check out Nue.Life here: https://nue.life/ ⏰ Timestamps: 0:00 intro and Juan...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
The Brom Podcast covers the emerging psychedelics industry from a business, investing, cultural and social impact perspective. Episodes feature psychedelic CEOs, scientists, investors, and other change-makers operating in the weird, wonderful world of psychedelic medicine.Brom Rector is the founder and general partner of Empath Ventures, a venture capital fund that invests in early stage startups focused on psychedelic medicine.
HOSTED BY
Brom Rector and Empath Ventures
CATEGORIES
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Brom Podcast have?
Brom Podcast currently has 45 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Brom Podcast about?
The Brom Podcast covers the emerging psychedelics industry from a business, investing, cultural and social impact perspective. Episodes feature psychedelic CEOs, scientists, investors, and other change-makers operating in the weird, wonderful world of psychedelic medicine.Brom Rector is the founder...
How often does Brom Podcast release new episodes?
Brom Podcast has 45 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Brom Podcast?
You can listen to Brom Podcast on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Brom Podcast?
Brom Podcast is created and hosted by Brom Rector and Empath Ventures.
URL copied to clipboard!